<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05612802</url>
  </required_header>
  <id_info>
    <org_study_id>KA22/178</org_study_id>
    <nct_id>NCT05612802</nct_id>
  </id_info>
  <brief_title>A New Marker for Early Diagnosis of Pneumoperitoneum-Related Acute Kidney Injury: Insulin-Like Growth Factor-1 (IGF-1)</brief_title>
  <official_title>A New Marker for Early Diagnosis of Pneumoperitoneum-Related Acute Kidney Injury: Insulin-Like Growth Factor-1 (IGF-1)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Baskent University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Baskent University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In our study, to show the effect of pneumoperitoneum on acute kidney injury in patients&#xD;
      scheduled for laparoscopic surgery, NGAL and IGF-1 values will be measured before, after and&#xD;
      24 hours after pneumoperitoneum, and these values will be compared. In our study, we aimed to&#xD;
      investigate the effect of pneumoperitoneum applied on acute kidney injury in patients who&#xD;
      underwent laparoscopic surgery. Creatinine and NGAL have been used successfully in the&#xD;
      follow-up of acute kidney injury. Our study investigates whether IGF-1 will be an effective&#xD;
      indicator in acute kidney injury by comparing IGF-1 and NGAL values before pneumoperitoneum,&#xD;
      after pneumoperitoneum and at the postoperative 24th hour.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">February 8, 2023</start_date>
  <completion_date type="Anticipated">May 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">March 30, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Diagnosis of acute kidney injury in the early postoperative period with IGF-1 (insulin like growth factor-1)</measure>
    <time_frame>before pneumoperitoneum, after pneumoperitoneum, and at the postoperative 24th hour.</time_frame>
    <description>The researchers investigate whether IGF-1 will be an effective indicator in acute kidney injury by comparing IGF-1 and NGAL (Neutrophil gelatinase-associated lipocalin) values before pneumoperitoneum, after pneumoperitoneum and at the postoperative 24th hour.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Acute Kidney Injury (Nontraumatic)</condition>
  <condition>Pneumoperitoneum</condition>
  <arm_group>
    <arm_group_label>IGF</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Creatinine and NGAL have been used successfully in the follow-up of acute kidney injury. In our study, in order to show the effect of pneumoperitoneum on acute kidney injury in patients scheduled for laparoscopic surgery, NGAL and IGF-1 values will be measured before, after and 24 hours after pneumoperitoneum, and these values will be compared.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>IGF-1</intervention_name>
    <description>We need to diagnose acute kidney injury in the early postoperative period. The markers examined so far do not provide enough information to diagnose acute kidney injury early. For this reason, many different biomarkers are used in the early diagnosis of acute kidney injury in many parts of the world. Thanks to our research, we can recognise the development of acute kidney injury at an early stage and determine whether a previously unused biomarker (IGF-1) is effective in the early diagnosis of acute kidney injury.</description>
    <arm_group_label>IGF</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients aged 18-70 years of both sexes&#xD;
&#xD;
          -  ASA I-III Patients&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Obesity,&#xD;
&#xD;
          -  Chronic Kidney Disease,&#xD;
&#xD;
          -  Chronic Renal Failure,&#xD;
&#xD;
          -  Acute Renal Failure,&#xD;
&#xD;
          -  Peripheral and ischemic vascular disease,&#xD;
&#xD;
          -  Chronic Heart Failure,&#xD;
&#xD;
          -  History of anaphylaxis,&#xD;
&#xD;
          -  A-V block,&#xD;
&#xD;
          -  Creatinine level &gt;1.4,&#xD;
&#xD;
          -  Neuromuscular disease,&#xD;
&#xD;
          -  Malignant hypertension,&#xD;
&#xD;
          -  Pyelonephritis,&#xD;
&#xD;
          -  Urinary tract infectio,&#xD;
&#xD;
          -  Severe inflammation/possible sepsis,&#xD;
&#xD;
          -  Active malignancy,&#xD;
&#xD;
          -  Patients with surgery reversion to laparotomy,&#xD;
&#xD;
          -  Hemodynamic instability, need for vasopressors,&#xD;
&#xD;
          -  Severe bleeding requiring blood transfusion,&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>NEDİM ÇEKMEN, PHD</last_name>
    <role>Study Director</role>
    <affiliation>Baskent University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Çağla Yazar, MD</last_name>
    <phone>05454160779</phone>
    <email>cglyzr@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>DENADA HAKA, MD</last_name>
    <email>denadahaka97@gmail.com</email>
  </overall_contact_backup>
  <reference>
    <citation>Gumbert SD, Kork F, Jackson ML, Vanga N, Ghebremichael SJ, Wang CY, Eltzschig HK. Perioperative Acute Kidney Injury. Anesthesiology. 2020 Jan;132(1):180-204. doi: 10.1097/ALN.0000000000002968.</citation>
    <PMID>31687986</PMID>
  </reference>
  <reference>
    <citation>Marton Filho MA, Alves RL, Nascimento PD Junior, Tarquinio GDS, Mega PF, Pinheiro Modolo NS. Effects of pneumoperitoneum on kidney injury biomarkers: A randomized clinical trial. PLoS One. 2021 Feb 19;16(2):e0247088. doi: 10.1371/journal.pone.0247088. eCollection 2021.</citation>
    <PMID>33606739</PMID>
  </reference>
  <reference>
    <citation>Sun B, Fu A, Wang R, Zhang Y. Influence of carbon dioxide pneumoperitoneum on the growth hormone-insulin-like growth factor I axis in mid- and late-pregnancy rats. J Obstet Gynaecol Res. 2015 Sep;41(9):1394-8. doi: 10.1111/jog.12734. Epub 2015 Jun 22.</citation>
    <PMID>26098754</PMID>
  </reference>
  <reference>
    <citation>Srisawat N, Kongwibulwut M, Laoveeravat P, Lumplertgul N, Chatkaew P, Saeyub P, Latthaprecha K, Peerapornratana S, Tiranathanagul K, Eiam-Ong S, Tungsanga K. The role of intraoperative parameters on predicting laparoscopic abdominal surgery associated acute kidney injury. BMC Nephrol. 2018 Oct 22;19(1):289. doi: 10.1186/s12882-018-1081-4.</citation>
    <PMID>30348111</PMID>
  </reference>
  <verification_date>February 2023</verification_date>
  <study_first_submitted>September 6, 2022</study_first_submitted>
  <study_first_submitted_qc>November 8, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 10, 2022</study_first_posted>
  <last_update_submitted>February 6, 2023</last_update_submitted>
  <last_update_submitted_qc>February 6, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">February 8, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Baskent University</investigator_affiliation>
    <investigator_full_name>Çağla Yazar, MD</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumoperitoneum</mesh_term>
    <mesh_term>Acute Kidney Injury</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

